These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25797564)

  • 21. The role of mitochondria in stem cell biology.
    Nesti C; Pasquali L; Vaglini F; Siciliano G; Murri L
    Biosci Rep; 2007 Jun; 27(1-3):165-71. PubMed ID: 17484045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of mitochondrial diseases].
    Fang F
    Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):381-383. PubMed ID: 37011990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear transfer to prevent mitochondrial DNA diseases.
    Poulton J; Kennedy S; Oakeshott P; St John J
    Lancet; 2006 Sep; 368(9538):841. PubMed ID: 16950359
    [No Abstract]   [Full Text] [Related]  

  • 24. Delivering healthy mitochondria for the therapy of mitochondrial diseases and beyond.
    Liu CS; Chang JC; Kuo SJ; Liu KH; Lin TT; Cheng WL; Chuang SF
    Int J Biochem Cell Biol; 2014 Aug; 53():141-6. PubMed ID: 24842105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nuclear transfer to prevent mitochondrial DNA diseases: myth or reality?].
    Steffann J; Monnot S; Rötig A; Munnich A; Bonnefont JP
    Med Sci (Paris); 2010 Nov; 26(11):897-9. PubMed ID: 21106164
    [No Abstract]   [Full Text] [Related]  

  • 26. Nuclear transfer to prevent maternal transmission of mitochondrial DNA disease.
    Poulton J; Oakeshott P
    BMJ; 2012 Oct; 345():e6651. PubMed ID: 23034858
    [No Abstract]   [Full Text] [Related]  

  • 27. Over-expression of Tfam improves the mitochondrial disease phenotypes in a mouse model system.
    Nishiyama S; Shitara H; Nakada K; Ono T; Sato A; Suzuki H; Ogawa T; Masaki H; Hayashi J; Yonekawa H
    Biochem Biophys Res Commun; 2010 Oct; 401(1):26-31. PubMed ID: 20816751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mitochondrial DNA-based disease model mice].
    Nakada K; Inoue K; Hayashi J; Nakada K; Hayashi J; Inoue K
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():688-92. PubMed ID: 12013974
    [No Abstract]   [Full Text] [Related]  

  • 29. The neurology of mitochondrial DNA disease.
    McFarland R; Taylor RW; Turnbull DM
    Lancet Neurol; 2002 Oct; 1(6):343-51. PubMed ID: 12849395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preventing mitochondrial diseases?].
    Nau JY
    Rev Med Suisse; 2010 Apr; 6(246):890-1. PubMed ID: 20455390
    [No Abstract]   [Full Text] [Related]  

  • 31. In support of mitochondrial replacement therapy.
    Adashi EY; Caplan AL; Capron A; Chapman AR; Cho M; Clayton EW; Cohen IG; Cook-Deegan R; Faden RR; Friedmann T; Gostin LO; Greely HT; Johnston J; Juengst E; King PA; Knowles LP; Lyerly AD; McGuire AL; Moreno JD; Rothenberg K; Truog RD; Walters L
    Nat Med; 2019 Jun; 25(6):870-871. PubMed ID: 31160819
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mouse models for mitochondrial DNA-based diseases].
    Nakada K; Hayashi J
    Tanpakushitsu Kakusan Koso; 2005 Nov; 50(14 Suppl):1774-7. PubMed ID: 16318313
    [No Abstract]   [Full Text] [Related]  

  • 33. Understanding heterogeneous diseases in mtDNA maintenance.
    Copeland WC
    Methods; 2010 Aug; 51(4):363. PubMed ID: 20682411
    [No Abstract]   [Full Text] [Related]  

  • 34. Mitochondrial DNA medicine.
    DiMauro S
    Biosci Rep; 2007 Jun; 27(1-3):5-9. PubMed ID: 17484047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mitochondrial replacement--potential therapy method with ethical implications. Severe disease may be prevented, but knowledge gaps exist].
    Ramsay KW; Hanson C; Asplund K
    Lakartidningen; 2014 Jul 16-Aug 5; 111(29-31):1240-3. PubMed ID: 25180425
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathology of the first model mouse for mitochondrial DNA-based diseases and interaction theory of mammalian mitochondria].
    Nakada K; Inoue K; Ono T; Hayashi J
    Tanpakushitsu Kakusan Koso; 2003 Mar; 48(4 Suppl):487-92. PubMed ID: 12696158
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethics of mitochondrial gene replacement: from bench to bedside.
    Bredenoord AL; Braude P
    BMJ; 2010 Nov; 341():c6021. PubMed ID: 21059727
    [No Abstract]   [Full Text] [Related]  

  • 38. Assembly factors as a new class of disease genes for mitochondrial complex I deficiency: cause, pathology and treatment options.
    Nouws J; Nijtmans LG; Smeitink JA; Vogel RO
    Brain; 2012 Jan; 135(Pt 1):12-22. PubMed ID: 22036961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-parent embryo: The therapeutic future for inherited mitochondrial diseases.
    Liu HS; Chu PL
    J Formos Med Assoc; 2015 Nov; 114(11):1027-8. PubMed ID: 24951160
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitochondrial diseases: a nosological update.
    Filosto M; Mancuso M
    Acta Neurol Scand; 2007 Apr; 115(4):211-21. PubMed ID: 17376118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.